Skeletal muscle angiogenesis: A possible role for hypoxia

Advances in Experimental Medicine and Biology

Volumn 502, Issue , 2001, Pages 21-38

  Wagner, Peter D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Exercise; Hypoxia inducible factor (HIF l ); Nitric oxide (NO); Proton magnetic resonance spectroscopy; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; ENDURANCE; EXERCISE; GENETIC TRANSCRIPTION; HYPOXIA; MOLECULAR BIOLOGY; MUSCLE BLOOD FLOW; MUSCLE CAPILLARY; MUSCLE CONTRACTION; NONHUMAN; OXYGEN SUPPLY; PRIORITY JOURNAL; PROTEIN SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE;

ANIMALIA;

EID: 0035574141     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-3401-0_4     Document Type: Conference Paper

References (36)

1. Dual influence of nitric oxide on gene regulation during hypoxia
2. 2 in dog gastrocnemius muscle in situ
3. Effect of NO, vasodilator prostaglandins and adenosine on skeletal muscle angiogenic growth factor gene expression
4. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise
5. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin
6. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements
7. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
8. The vascular endothelial growth factor family of polypeptides
9. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
10. Effects of exercise and nitric oxide synthase inhibition on skeletal muscle VEGF receptor mRNA
11. Angiogenesis: New targets for the development of anticancer chemotherapies
12. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation
13. Theoretical analysis of oxygen supply to contracted skeletal muscle
14. 2 diffusing capacity: Evidence from muscle function in situ
15. 2 delivery in dog muscle in situ
16. Influence of chronic nitric oxide inhibition on muscle capillarization
17. 2 gradients from hemoglobin to cytochrome: New concepts, new complexities
18. The number and distribution of capillaries in muscle with calculations of the pressure head necessary for supplying the tissue
19. Molecular medicine in genetically engineered animals. Recent advances in gene mutagenesis by site-directed recombination
20. Capillary-to-fiber surface ratio in rat fast-twitch hindlimb muscles after chronic electrical stimulation
21. Uremic myopathy limits aerobic capacity in hemodialysis patients
22. Challenging beliefs: Ex Africa semper aliquid novi
23. Maximal oxygen uptake: "Classical" versus "contemporary" viewpoints: A rebuttal
24. Role of endothelium-derived relaxing factor in hindlimb reactive and active hyperemia in conscious dogs
25. 2 transport
26. 2 delivery in dog muscle in situ
27. 2max in normal humans
28. Skeletal muscle adaptability: Significance for metabolism and performance
29. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1
30. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
31. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure
32. Relationship between HIF and VEGF responses to moderate hypoxia and to sciatic nerve stimulation in rat gastrocnemius muscle
33. Determinants of maximal oxygen transport and utilization
34. Determinants of maximal oxygen uptake
35. Muscle angiogenic growth factor gene responses to exercise in chronic renal failure